|
Dr. Babiuk is the Director of the Vaccine and Infectious Disease Organization (VIDO) and Canada Research Chair in Vaccinology and Biotechnology in Saskatoon, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. Under his direction, VIDO has become internationally recognized for its role in the use of biotechnology to develop vaccines. The world's first genetically engineered vaccine for animal species was developed at VIDO. Dr. Babiuk is an Officer of the Order of Canada and received the Prix Galien Canada Research Award for 2005. He has received the Saskatchewan Order of Merit and has held prestigious national and international awards for excellence in research and for transferring research into the commercial arena, including an NSERC Chair in Biotechnology, Canadian Society of Microbiology Award, and Xerox-Canada Forum Award. He has served as a member of the Scientific Advisory Board or Board of Directors for numerous companies involved in commercializing biological research, and as a consultant to Genetech, Molecular Genetics Inc., and CIBA-GIEGY; and he has conducted due diligence studies for investors and companies regarding the commercial potential of specific scientific proposals. He currently chairs the Board of Directors of the International Centre for Infectious Diseases (ICID) and the Institute Advisory Board of the CIHR Institute of Infection and Immunity. He has mentored more than 90 graduate students and post-doctoral fellows who have obtained positions in industry, academia and government, served as a member of many grant and government committees and a reviewer for various scientific journals, as well as serving on general editorial boards. He has published more than 500 peer-reviewed manuscripts and 100 book chapters and reviews, and is holder of 25 issued patents and 18 patents pending. His specialty areas are molecular virology, vaccinology, immunology and viral pathogenesis with emphasis on respiratory and viral infections. Recent interest has been in novel vaccine development using genomics, and in delivery to induce mucosal immunity, as well as helping set science policy in Canada. | 